Peptonic Medical is a biomedical company that conducts research and development of pharmaceuticals and medical devices in the field of women's health. The company's vision is to offer treatments for women-specific diseases and medical conditions. For example, hormone-free products are being developed for the treatment of vaginal atrophy and vaginal dryness. Peptonic Medical has its headquarters in Bromma.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Maida Vale Capital AB | 29,19 | 29,19 | 2026-03-27 |
| Fenja Capital Partners A/S | 19,85 | 19,85 | 2026-03-27 |
| Heli Kurjanen | 3,71 | 3,71 | 2023-12-31 |
| Nordnet Pensionsförsäkring | 2,86 | 2,86 | 2026-03-27 |
| Henrik Hahn | 2,33 | 2,33 | 2026-03-27 |
| Mika Kurjanen | 1,93 | 1,93 | 2023-12-31 |
| Patrick Bergström | 1,85 | 1,85 | 2026-03-27 |
| Mendicom Oy | 1,45 | 1,45 | 2026-03-27 |
| Lars Erik Eurenius | 1,33 | 1,33 | 2026-03-27 |
| Avanza Pension | 1,32 | 1,32 | 2026-03-27 |
2026-11-10 Interim Report 2026-Q3
2027-02-23 Year End Report 2026
